Meyer Pharmaceuticals entered the industry of Medical Research in 1999 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417110, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Michael O'Neill, President by calling (949) 833-0711 during business hours. You can also write to the business’ Single Location at 1761 Kaiser Avenue, Irvine, California CA 92614. You can also visit the company’s website at meyerpharm.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Meyer Pharmaceuticals |
Representative: | Michael O'Neill, President |
Place of Business: | 1761 Kaiser Avenue, Irvine, CA 92614 |
Contact Number: | (949) 833-0711 |
Website: | meyerpharm.com |
Type of Service: | Medical Research |
SIC Number: | 8733 |
NAICS Number: | 5417110 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 1999 |
Income/Year: | Unknown |
Laborers: | 1 to 4 |
Share This Company: |
Meyer Pharmaceuticals is a company operating from Orange, California providing professional Medical Research and relevant B2B variables. It was founded in 1999 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 5417110 as Medical Research.
With a current employee count of 1 to 4, Meyer Pharmaceuticals has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Michael O'Neill, President at (949) 833-0711 for related queries, or to locate its Single Location using the coordinates 33.69381,-117.84892.
The Single Location can also be found at the street address 1761 Kaiser Avenue in Irvine, California 92614 and can be engaged online through the company website at meyerpharm.com, the company Twitter , and Facebook page .